Gain Therapeutics, Inc. (GANX)
USD 1.54
(-8.33%)
USD 1.54
(-8.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 55.18 Thousand | 140.1 Thousand | 164.99 Thousand | 28.88 Thousand | 41.3 Thousand | 20.6 Thousand |
| Cost of Revenue | 11.37 Million | 64.16 Thousand | 7.16 Million | 2.25 Million | - | - |
| Gross Profit | -11.32 Million | 75.94 Thousand | -6.99 Million | -2.23 Million | 41.3 Thousand | 20.6 Thousand |
| Operating Expenses | 22.3 Million | 17.91 Million | 13.99 Million | 3.5 Million | 2.14 Million | 1.04 Million |
| Selling, General and Administrative Expenses | 10.78 Million | 9.53 Million | 6.82 Million | 1.24 Million | 555.16 Thousand | 222.04 Thousand |
| Research and Development Expenses | 11.52 Million | 8.37 Million | 7.16 Million | 2.25 Million | 1.58 Million | 826.88 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 22.3 Million | 17.91 Million | 13.99 Million | 3.5 Million | 2.14 Million | 1.04 Million |
| Operating Income | -22.25 Million | -17.77 Million | -13.82 Million | -3.47 Million | -2.1 Million | -1.02 Million |
| Interest Expense | - | - | - | - | 20.54 Thousand | - |
| Income Tax Expense | 79.27 Thousand | 92.97 Thousand | 4008.00 | 5386.00 | 7114.00 | 9781.00 |
| Earnings before Tax | -22.18 Million | -17.49 Million | -13.88 Million | -3.57 Million | -2.18 Million | -1.09 Million |
| Net Income | -22.26 Million | -17.59 Million | -13.89 Million | -3.57 Million | -2.19 Million | -1.1 Million |
| Earnings Per Share Basic | -1.71 | -1.48 | -1.37 | -0.30 | -0.18 | -0.19 |
| Earnings Per Share Diluted | -1.71 | -1.48 | -1.37 | -0.30 | -0.18 | -0.19 |
| Weighted Average Shares Outstanding | 13.01 Million | 11.88 Million | 10.16 Million | 11.87 Million | 11.87 Million | 5.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.01 Million | 11.88 Million | 10.16 Million | 11.87 Million | 11.87 Million | 5.86 Million |
| Gross Margin | -205.22 | 0.54 | -42.42 | -77.22 | 1.00 | 1.00 |
| EBIT Margin | -401.77 | -126.20 | -83.36 | -116.80 | -49.20 | -49.13 |
| Profit Margin | -403.54 | -125.55 | -84.19 | -123.88 | -53.11 | -53.64 |
| EBITDA | -22.16 Million | -17.77 Million | -13.82 Million | -3.46 Million | -2.09 Million | -1.02 Million |
| Earnings Before Tax Margin | -403.28 | -126.88 | -83.80 | -120.48 | -50.85 | -49.90 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 55.18 Thousand | 64.8 Thousand | - | - |
| Cost of Revenue | 20.59 Thousand | 20.52 Thousand | 80.38 Thousand | 23.58 Thousand | 20.5 Thousand | 20.23 Thousand |
| Gross Profit | -20.59 Thousand | -20.52 Thousand | -25.2 Thousand | 41.21 Thousand | -20.5 Thousand | -20.23 Thousand |
| Operating Expenses | 8.16 Million | 4.35 Million | 22.22 Million | 4.38 Million | 4.88 Million | 7.73 Million |
| Selling, General and Administrative Expenses | 3.73 Million | 1.85 Million | - | 2.01 Million | 2.51 Million | 3.74 Million |
| Research and Development Expenses | 4.42 Million | 2.49 Million | - | 2.36 Million | 2.36 Million | 3.98 Million |
| Other Expenses | -476.73 Thousand | - | - | - | - | - |
| Cost and Expenses | 8.18 Million | 4.37 Million | 22.3 Million | 4.4 Million | 4.88 Million | 7.73 Million |
| Operating Income | -8.18 Million | -4.37 Million | -22.25 Million | -4.4 Million | -4.88 Million | -7.73 Million |
| Interest Expense | - | - | - | -152.03 Thousand | - | - |
| Income Tax Expense | 1209.00 | 19.87 Thousand | 79.27 Thousand | 14.5 Thousand | 21.45 Thousand | 26.58 Thousand |
| Earnings before Tax | -8.14 Million | -3.99 Million | -22.18 Million | -4.7 Million | -4.69 Million | -7.66 Million |
| Net Income | -8.14 Million | -4.01 Million | -22.26 Million | -4.72 Million | -4.71 Million | -7.68 Million |
| Earnings Per Share Basic | -0.42 | -0.22 | - | -0.29 | -0.37 | -0.62 |
| Earnings Per Share Diluted | -0.42 | -0.22 | - | -0.29 | -0.37 | -0.62 |
| Weighted Average Shares Outstanding | 19.21 Million | 17.97 Million | 13.01 Million | 16.2 Million | 12.7 Million | 12.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.21 Million | 17.97 Million | 13.01 Million | 16.2 Million | 12.7 Million | 12.38 Million |
| Gross Margin | - | - | -0.46 | 0.64 | - | - |
| EBIT Margin | - | - | - | -67.65 | - | - |
| Profit Margin | - | - | -403.54 | -72.90 | - | - |
| EBITDA | -8.16 Million | -4.35 Million | - | -4.38 Million | -4.96 Million | -7.65 Million |
| Earnings Before Tax Margin | - | - | -403.28 | -68.01 | - | - |
PHL
BALM3
FND
GVDI
8027
CMPGY